Max India Ltd

Max India Ltd announced that Mr. Rohit Kapoor has resigned from his position as Non-Executive Independent Director, effective July 1, 2026. The resignation is due to increased other professional commitments. Mr. Kapoor confirmed there are no other material reasons for his departure. The company has provided the necessary disclosures as per SEBI Listing Regulations.

Max India Ltd announced that Mr. Rohit Kapoor has resigned from his position as Non-Executive Independent Director, effective July 1, 2026. The resignation is due to increased other professional commitments. Mr. Kapoor confirmed there are no other material reasons for his departure. The company has filed the necessary disclosures as per SEBI Listing Regulations. The event occurred at 11:03 a.m. today.

Max India Ltd has announced the resignation of Mr. Rohit Kapoor from his position as Non-Executive Independent Director. The resignation is effective from July 1, 2026. The reason cited for his departure is increased other professional commitments, which will prevent him from dedicating sufficient time to the Board. Mr. Kapoor confirmed that there are no other material reasons for his resignation beyond those stated. The company has taken this information on record as per SEBI Listing Regulations.

Max India Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This restriction on trading in the company's shares will be in effect from Wednesday, July 1, 2026, until 48 hours after the announcement of the unaudited financial results for the quarter ending June 30, 2026. This measure is in compliance with the company's policy on the prevention of insider trading and SEBI regulations.

Max India Ltd announced that its Nomination and Remuneration Committee approved the grant of 8,74,227 Employee Stock Options (ESOPs) under the MIL Employee Stock Option Plan 2020. The company also approved the allotment of 60,000 equity shares arising from the exercise of vested stock options. This allotment increases the company's issued, subscribed, and paid-up capital from ₹52,52,28,620 to ₹52,58,28,620. The ESOP grant price is set at ₹80.02 per option, representing 50% of the average market price as of June 5, 2026. Vesting is scheduled over four years, with exercise possible within five years from vesting dates.

Max India's wholly-owned subsidiary, Antara Senior Care, has launched the Antara Integrated Wellness Clinic (AIWC) in Gurugram. This clinic offers integrative medicine, combining modern medical practices with evidence-based holistic therapies like Ayurveda and energy healing, to manage chronic conditions in seniors. The initiative aims to address the growing healthcare needs of India's aging population by providing personalized, multidisciplinary care that focuses on the root cause of illnesses and improves overall quality of life, bridging the gap between lifespan and health span.

Max India Limited confirmed that there was no deviation or variation in the utilization of proceeds from its Rights Issue during the quarter ended March 31, 2026. This compliance is in accordance with Regulation 32(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The funds were utilized as per the objects stated in the Letter of Offer dated April 25, 2025. The Rights Issue, dated May 23, 2025, raised ₹124.23 Crores. Additionally, the company also confirmed no deviation for a Preferential Issue dated September 24, 2025, for which ₹40.17 Crores (50% consideration) out of ₹80.35 Crores was received. CARE Ratings Limited is the monitoring agency for the Rights Issue.

The Board of Directors of Max India Limited, in its meeting on May 28, 2026, approved several key items. These include the re-appointment of MGC Global Risk Advisory LLP as Internal Auditors for FY 2026-27 and an amendment to the Company's Related Party Transaction policy. The Board also approved the reallocation of unutilised proceeds from the Rights Issue, amounting to ₹124.23 Crore, which will be subject to shareholder approval. This reallocation involves adjustments to funds for performance marketing and brand marketing. Additionally, the Board sanctioned the issuance of corporate guarantees up to ₹75 Crores for loan facilities to be availed by its wholly-owned subsidiaries. The trading window for the company's securities remains closed until May 30, 2026.

Max India Limited's Board of Directors, in its meeting on May 28, 2026, approved several key decisions. These include the re-appointment of M/s MGC Global Risk Advisory LLP as Internal Auditors for the financial year 2026-27 and an amendment to the Company’s policy on Related Party Transactions. The Board also considered and approved the reallocation of an unutilised portion of ₹124.23 Crore from the Rights Issue proceeds, which will be subject to shareholder approval. Furthermore, the Board sanctioned the issuance of corporate guarantee(s) up to ₹75 Crores for proposed loan facilities to be availed by its wholly-owned subsidiary(ies). The trading window remains closed until May 30, 2026.

Max India Limited's Board of Directors, in a meeting held on May 28, 2026, approved several key items. These include the re-appointment of M/s MGC Global Risk Advisory LLP as Internal Auditors for the financial year 2026-27 and an amendment to the Company’s policy on Related Party Transactions. The Board also approved the reallocation of the unutilized portion of Rights Issue proceeds, amounting to ₹124.23 Crore, which is subject to shareholder approval. Additionally, the issuance of corporate guarantee(s) up to ₹75 Crores for proposed loan facilities by wholly-owned subsidiaries was approved, pending requisite sanctions. The trading window for the company's securities remains closed until May 30, 2026, following the declaration of audited financial results for the quarter and year ended March 31, 2026.